002728 logo

Teyi Pharmaceutical Group Co.,Ltd Stock Price

SZSE:002728 Community·CN¥5.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002728 Share Price Performance

CN¥0
-8.15 (-100.00%)
CN¥0
-8.15 (-100.00%)
Price CN¥0

002728 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

2 Risks
2 Rewards

Teyi Pharmaceutical Group Co.,Ltd Key Details

CN¥924.5m

Revenue

CN¥421.2m

Cost of Revenue

CN¥503.4m

Gross Profit

CN¥421.7m

Other Expenses

CN¥81.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 28, 2026
0.16
54.45%
8.83%
14.5%
View Full Analysis

About 002728

Founded
2002
Employees
1341
CEO
Danqing Xu
WebsiteView website
www.tczy.com.cn

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company’s products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 and is based in Taishan City, the People’s Republic of China.

Recent 002728 News & Updates

Recent updates

No updates